By using this site, you agree to the Privacy Policy and Terms of Use.

Notification Show More

Home
Automobile
Entertainment
Esports
Food
Health
Life Style
Technology
Travel

Entertainment
Technology

Search

Home
Automobile
Entertainment
Esports
Food
Health
Life Style
Technology
Travel

Have an existing account? Sign In

Follow US

Tag: JPX:4875.T

MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

December 05, 2024 18:00 ET | Source: MediciNova, Inc. LA JOLLA, Calif.,…

GlobeNews Wire December 6, 2024

MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis

MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis

November 11, 2024 18:00 ET | Source: MediciNova, Inc. LA JOLLA, Calif.,…

GlobeNews Wire November 12, 2024

Categories

Uncategorized
Health
Automobile
Travel
Esports
Technology
Entertainment
Life Style
Food

About US

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

Email address:

Leave this field empty if you’re human:

Copyright © 2021 - 2024 AdKhabar. All Rights Reserved. POWERED BY Life Care News.

Welcome Back!

Sign in to your account

Username or Email Address

Password

Remember me

Lost your password?